Vanguard Group’s Cellectar Biosciences CLRB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $401K | Sell |
|
|||||
|
2025
Q1 | $542K | Sell |
|
|||||
|
2024
Q4 | $516K | Buy |
|
|||||
|
2024
Q3 | $3.7M | Buy |
|
|||||
|
2024
Q2 | $3.91M | Buy |
|
|||||
|
2024
Q1 | $4.74M | Buy |
|
|||||
|
2023
Q4 | $1.34M | Buy |
|
|||||
|
2023
Q3 | $464K | Buy |
|
|||||
|
2023
Q2 | $335K | Sell |
|
|||||
|
2023
Q1 | $251K | Hold |
|
|||||
|
2022
Q4 | $300K | Buy |
|
|||||
|
2022
Q3 | $589K | Hold |
|
|||||
|
2022
Q2 | $708K | Hold |
|
|||||
|
2022
Q1 | $1.21M | Sell |
|
|||||
|
2021
Q4 | $1.3M | Sell |
|
|||||
|
2021
Q3 | $1.82M | Buy |
|
|||||
|
2021
Q2 | $2.23M | Buy |
|
|||||
|
2021
Q1 | $2.65M | Buy |
|
|||||
|
2020
Q4 | $3.15M | Buy |
|
|||||
|
2020
Q3 | $88K | Buy |
|
|||||
|
2020
Q2 | $21K | Hold |
|
|||||
|
2020
Q1 | $22K | Hold |
|
|||||
|
2019
Q4 | $38K | Hold |
|
|||||
|
2019
Q3 | $34K | Hold |
|
|||||
|
2019
Q2 | $37K | Hold |
|
|||||
|
2019
Q1 | $39K | Hold |
|
|||||
|
2018
Q4 | $26K | Hold |
|
|||||
|
2018
Q3 | $50K | Sell |
|
|||||
|
2018
Q2 | $153K | Buy |
|
|||||
|
2018
Q1 | $277K | Buy |
|
|||||
|
2017
Q4 | $325K | Buy |
|
|||||
|
2017
Q3 | $246K | Hold |
|
|||||
|
2017
Q2 | $240K | Buy |
|
|||||
|
2017
Q1 | $253K | Buy |
|
|||||
|
2016
Q4 | $85K | Buy |
|
|||||
|
2016
Q3 | $111K | Buy |
|
|||||
|
2016
Q2 | $81K | Buy |
|